Health
First Randomized Trial Reassures on ACEIs, ARBs in COVID-19 – Medscape
The BRACE CORONA study found no difference in key outcomes between patients continuing vs stopping their medication.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
The first randomized study to compare continuing vs stopping angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for patients with COVID-19 has shown no difference in key outcomes between the two approaches.
The BRACE CORONA trial conducted in patients had been taking an ACE inhibitor or an ARB on a long-term basis and who were subsequently hospitalized with C…
-
Noosa News18 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General22 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News11 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General11 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final